Filing Details
- Accession Number:
- 0001645627-17-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-05 15:10:00
- Reporting Period:
- 2017-06-30
- Filing Date:
- 2017-07-05
- Accepted Time:
- 2017-07-05 15:10:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,410,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,412,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 1,000 | $0.03 | 21,413,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,415,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 1,000 | $0.03 | 21,416,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 1,000 | $0.03 | 21,417,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,419,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,421,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,423,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,425,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,427,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,429,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,431,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,433,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 3,000 | $0.03 | 21,436,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,438,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,440,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,442,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,444,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,446,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 3,000 | $0.03 | 21,449,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,451,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 1,000 | $0.03 | 21,452,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 1,000 | $0.03 | 21,453,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,455,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,457,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,459,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,461,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,463,349 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 2,000 | $0.03 | 21,465,349 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
